US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

157.47

+1.230.79%

Post-market: 157.00-0.4700-0.30%17:08 EDT

Volume:418.21K

Turnover:66.36M

Market Cap:507.76M

PE:- -

High:161.26

Open:157.46

Low:155.50

Close:156.24

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:0.60

T/O Rate:12.97%

Dividend:1.34

Dividend Rate:0.85%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment+0.37%

Fractional Shares+0.37%

Capital Flow

Inflow:

Outflow:

News

Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)

Lantheus announces three-month extension of LNTH-2501 PDUFA date

Press Release: Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":157.47,"timestamp":1773777600000,"preClose":156.24,"halted":0,"volume":418206,"hourTrading":{"tag":"盘后","latestPrice":157,"preClose":157.47,"latestTime":"17:08 EDT","volume":673,"amount":105954.3607,"timestamp":1773781710457,"change":-0.47,"changeRate":-0.002985,"amplitude":0.010161},"delay":0,"changeRate":0.00787250384024571,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Post-Mkt","change":1.23,"latestTime":"03-17 17:11:46 EDT","open":157.46,"high":161.26,"low":155.5,"amount":66362801.64288,"amplitude":0.036866,"askPrice":157.8,"askSize":200,"bidPrice":156.6,"bidSize":100,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1773792000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.24,"sharesOutstanding":3074486,"nav":149.06,"aum":480642683.13,"dividendRate":0.008533,"bidAskSpread":0.002274,"preHourTrading":{"tag":"盘前","latestPrice":157.98,"preClose":156.24,"latestTime":"09:28 EDT","volume":3731,"amount":579161.18988,"timestamp":1773754129536,"change":1.74,"changeRate":0.011137,"amplitude":0.022721},"postHourTrading":{"tag":"盘后","latestPrice":157,"preClose":157.47,"latestTime":"17:08 EDT","volume":673,"amount":105954.3607,"timestamp":1773781710457,"change":-0.47,"changeRate":-0.002985,"amplitude":0.010161},"volumeRatio":0.598861,"impliedVol":1.0319,"impliedVolPercentile":0.8526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.598861,"shares":3224486,"dividePrice":1.3437,"high":161.26,"amplitude":0.036866,"preClose":156.24,"low":155.5,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":157.47,"committee":-0.333333,"eps":0,"divideRate":0.008533,"volume":418206,"delay":0,"ttmEps":0,"open":157.46,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":171.5,"twentyDayClose":162.07,"sixtyDayClose":156.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620403064","title":"Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403064?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:40","pubTimestamp":1773780027,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Canopy Growth (CGC – Research Report) and Doximity (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-canopy-growth-cgc-and-doximity-docs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-canopy-growth-cgc-and-doximity-docs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","DOCS","BK4137","LU0029874061.USD","BK4588","CGC","BK4585","XLV","BK4613","LU0128526141.USD","BK4581","LABU","HCSG","XBI","BK4557","BK4539","BK4007","BK4551"],"gpt_icon":0},{"id":"2620403180","title":"Lantheus announces three-month extension of LNTH-2501 PDUFA date","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403180?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:22","pubTimestamp":1773778920,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) announced that the FDA has extended its review of the new drug application for LNTH-2501 by three months to June 29. The extension ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantheus-announces-three-month-extension-of-lnth-2501-pdufa-date-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantheus-announces-three-month-extension-of-lnth-2501-pdufa-date-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4198","LNTH","BK4585"],"gpt_icon":0},{"id":"2620682408","title":"Press Release: Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2620682408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620682408?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:05","pubTimestamp":1773777900,"startTime":"0","endTime":"0","summary":"Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough. On track to initiate a Phase 2b clinical trial for the treatment of patients with refractory chronic cough in the second quarter of 2026. Company ended 2025 with $188.3 million in cash, cash equivalents and marketable securities, with expected cash runway into 2028. Management to host a conference call and webcast today at 4:30 p.m. ET. NEW HAVEN, Conn., March 17, 2026  -- Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio  for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis , non-IPF interstitial lung disease , and refractory chronic cough , today announced financial results for the fourth quarter and year ended December 31, 2025, and provided business updates.overall alignment on the plan for the remai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","RCC","BK4585","BK4539","TRVI","BK4604","LABU","BK4139","TM","BK4588","LENZ","BK4555","BK4099","BK4007"],"gpt_icon":0},{"id":"2620477841","title":"UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620477841","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620477841?lang=en_us&edition=fundamental","pubTime":"2026-03-18 01:40","pubTimestamp":1773769200,"startTime":"0","endTime":"0","summary":"EAGLE, Idaho, March  17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/17/3257551/0/en/UPDATE-Pennant-Group-to-Participate-in-the-2026-Oppenheimer-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4185","BK4581","HCSG","XBI","XLV","BK4137","BK4588","LABU","LU0128526141.USD","PNTG","LU0029874061.USD","BK4127","BK4196","OPY"],"gpt_icon":0}],"pageSize":4,"totalPage":106,"pageCount":1,"totalSize":422,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABU\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.003655},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.003654}]}}